Goodeslor Tablet contains Desloratadine 5mg, a second-generation antihistamine indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria. Desloratadine selectively antagonizes peripheral histamine H1-receptors, thereby inhibiting the effects of histamine, a key mediator in allergic reactions. This action results in the alleviation of nasal and ocular symptoms such as sneezing, rhinorrhea, nasal congestion, and itching, as well as cutaneous manifestations including hives and pruritus. Goodeslor is characterized by minimal sedative effects due to its limited penetration of the blood-brain barrier, making it suitable for patients requiring daytime symptom control without impairment of cognitive or psychomotor functions. The recommended dosage for adults and adolescents aged 12 years and above is one 5mg tablet once daily, with adjustments based on clinical response and patient tolerance. Goodeslor should be used cautiously in patients with hepatic impairment, and dosage modification may be necessary. It is contraindicated in individuals with known hypersensitivity to Desloratadine or any excipients. Common adverse effects are generally mild and may include headache, fatigue, and dry mouth. Patients are advised to consult healthcare professionals before initiating therapy, particularly if pregnant, breastfeeding, or taking concomitant medications.